A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Medical Science Liaison

Biology & BiotechPosted on Nov 13
Full-timeParis, FranceNo salary listedRemote

About the Job

Requirements

  • A scientific degree or an equivalent qualification at master's level (Bac+5) is required.
  • Experience in medical affairs and MSL roles is required.
  • Experience analyzing and synthesizing literature is required.
  • Public speaking experience is required.
  • The ability to organize and prioritize one's own schedule is required.

Responsibilities

  • Provide accurate and balanced scientific and medical information, including clinical data, development information, and publications, in response to healthcare experts' and professionals' needs through one-to-one discussions or scientific meetings.
  • Provide scientific support and participate in conferences and meetings.
  • Respond appropriately to medical requests, including requests from hospital medical committees responsible for the proper use of medicines.
  • Participate in regional events and national and international congresses.
  • Identify medical experts and institutional networks in the region, including healthcare decision-makers and public health organizations, and strengthen relationships with the medical community.
  • Analyze environmental characteristics of Alnylam's therapeutic areas.
  • Implement and monitor regional medical plans.
  • Ensure the scientific quality and ethical conduct of projects.
  • Develop non-promotional regional medical initiatives in partnership with expert healthcare professionals in the region.
  • Convene and facilitate expert boards to develop projects.
  • Develop programs to optimize patient care, including care networks, information programs, and observatories.
  • Build and maintain peer-to-peer relationships to raise awareness of the correct use of Alnylam products and explore new uses.
  • Identify and select scientific study proposals from clinicians in the region.
  • Support headquarters teams and clinical operations in implementing and monitoring company-sponsored studies.
  • Provide a field medical interface for the compassionate-use program (CPC, formerly RTU).
  • Serve as the region's medical reference, providing scientific expertise and supporting the proper use of medicines.
  • Maintain an effective interface between the field and headquarters, including competitive intelligence and regular updates on market, competition, environment, and healthcare professionals' perceptions of products and services.
  • Update knowledge and participate in training field sales teams.
  • Maintain expertise in evolving scientific areas and competing medicines.
  • Communicate non-promotionally with healthcare professionals, respecting the separation of promotional and non-promotional activities under the promotional information charter.
  • Follow good clinical practices and Alnylam France's professional conduct rules.
  • Comply with transparency rules concerning relationships with healthcare professionals, students, and associations.
  • Ensure compliance with the law governing benefits (LEA), ethical standards, internal policies, and compliance requirements.
  • Report adverse events in accordance with company policy.

Desired Qualifications

  • Experience in cardiology is an advantage.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs